CENX (Century Aluminum Co) Stock Analysis - SEC Filings

Century Aluminum Co (CENX) is a publicly traded Basic Materials sector company. As of May 21, 2026, CENX trades at $59.48 with a market cap of $5.44B and a P/E ratio of 16.69. CENX moved +0.53% today. Year to date, CENX is +34.11%; over the trailing twelve months it is +263.51%. Its 52-week range spans $13.05 to $68.69. Analyst consensus is strong buy with an average price target of $79.33. Rallies surfaces CENX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CENX SEC filings?

Rallies organizes CENX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CENX Key Metrics

Key financial metrics for CENX
MetricValue
Price$59.48
Market Cap$5.44B
P/E Ratio16.69
EPS$3.52
Dividend Yield0.00%
52-Week High$68.69
52-Week Low$13.05
Volume100
Avg Volume0
Revenue (TTM)$2.54B
Net Income$312.10M
Gross Margin12.17%

Latest CENX News

Recent CENX Insider Trades

  • Trpkovski Peter A sold 16.74K (~$845.49K) on Mar 25, 2026.
  • Gary Jesse E sold 150.00K (~$8.32M) on Mar 16, 2026.
  • Calloway Kenneth L sold 18.00K (~$1.04M) on Mar 12, 2026.

CENX Analyst Consensus

3 analysts cover CENX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $79.33.

Common questions about CENX

Where can I find CENX SEC filings?
Rallies organizes CENX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CENX 10-K and 10-Q filings?
Rallies organizes CENX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CENX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CENX. It does not provide personalized investment advice.
CENX

CENX